Evelo Biosciences(EVLO) - 2019 Q2 - Quarterly Report
Evelo BiosciencesEvelo Biosciences(US:EVLO)2019-08-06 20:45
Transcript

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 | --- | --- | |--------------------------------------------------------------|---------------------------------| | For the transition period from | to | | Commission File Num ...